Global /South Korea /Basic Materials /Specialty Chemicals /307750

Kookjeon Pharmaceutical Co., Ltd.

307750

• KRX: 307750 • Delayed

3,910KRW -2.3%

2.56 USD

As of 13 June 2026, Kookjeon Pharmaceutical Co., Ltd. has a market cap of $138.8M USD, ranking #23350 globally and #1024 in South Korea. It ranks #2498 in the Basic Materials sector, and #777 in the Specialty Chemicals industry.

Global Rank

23350

Country Rank

1024

Sector Rank

2498

Industry Rank

777

Key Stats

Market Cap

$138.8MUSD

211.09B KRW

Enterprise Value

$148.08MUSD

226.0B KRW

Revenue (TTM)

$86.16MUSD

131.04B KRW

EBITDA (TTM)

$1.75MUSD

2.66B KRW

Net Income (TTM)

-$2.83MUSD

-4.3B KRW

EBITDA Margin

Profit Margin

-3.3%

PS Ratio

1.6

PB Ratio

2.2

EV/EBITDA

87.3

Company Profile

Country (HQ)

South Korea

Sector

Basic Materials

Industry

Specialty Chemicals

CEO

Jongho Hong open_in_new

Employees

178

Founded

1972

Website

kukjeon.co.kr open_in_new

warningChart data may be delayed

1d	1w	1m	3m	6m	YTD	1y	3y	5y
-2.3%	3.1%	-13%	22%	7%	19%	25%	-36%	-47%

News

Markets

Exchange	Ticker	Price	Quotes
Korea Exchange (KRX) MIC: XKRX PRIMARY	307750 (주)국전약품 Ordinary Shares ISIN: KR7307750000 Shares Out.: Shares Outstanding: 53.986M¹ Shares Float: 25.695M² TV: TradingView: KRX: 307750 SA: Stock Analysis: KRX: 307750 YF: Yahoo Finance: 307750.KS GF: Google Finance: KRX: 307750 BA: Barron's: 307750 MS: Morningstar: XKRX: 307750	3,910 KRW	TV: TradingView: KRX: 307750 SA: Stock Analysis: KRX: 307750 YF: Yahoo Finance: 307750.KS GF: Google Finance: KRX: 307750 BA: Barron's: 307750 MS: Morningstar: XKRX: 307750

¹Market cap is calculated using shares outstanding.

²Float shares are publicly tradable shares, excluding insider-held stock.

About Kookjeon Pharmaceutical Co., Ltd.

Kookjeon Pharmaceutical Co., Ltd. operates as a chemical total solutions provider in South Korea. It provides various chemical-based products and services; and after-sales services, such as research and development, production, quality control, and DMF services. The company manufactures active pharmaceutical ingredients; and offers molecular design and technical support. It develops electronic materials, such as antistatic agents, monomers and polymers with low dielectric constant, and UV curing agents; low-resistance electrolyte, phosphine, silane, and boron compounds; semiconductor materials; and carbazole, boric acid, and fluorene intermediates. In addition, the company owns patents for its manufacturing methods. It serves pharmaceuticals, intermediate products, new drug synthesis, and related materials industries. The company was founded in 1972 and is headquartered in Anyang-si, South Korea.

Similar Companies

Industry: Specialty Chemicals (South Korea)

Name	Market Cap (USD) diff.	PE	Country
LG Chem, Ltd. KRX: 051910	$19.37B 29.46T KRW 14K%	-	South Korea
Hanwha Corp. KRX: 000880	$5.67B 8.63T KRW 4K%	32.6	South Korea
OCI Holdings Company Ltd. KRX: 010060	$4.56B 6.94T KRW 3K%	-	South Korea
Ecopro Materials Co., Ltd. KRX: 450080	$3.88B 5.91T KRW 3K%	259.1	South Korea
Lotte Chemical Corp. KRX: 011170	$3.16B 4.8T KRW 2K%	-	South Korea
KCC Corp. KRX: 002380	$2.79B 4.24T KRW 2K%	2.8	South Korea

Industry: Specialty Chemicals (Global)

Name	Market Cap (USD) diff.	PE	Country
Linde plc NASDAQ: LIN	$233.88B 168K%	34.5	United Kingdom
Air Liquide S.A. EPA: AI	$121.12B 104.79B EUR 87K%	29.9	France
Shin-Etsu Chemical Co., Ltd. TSE: 4063	$82.13B 13.15T JPY 59K%	28.0	Japan
The Sherwin-Williams Co. NYSE: SHW	$77.94B 56K%	30.5	United States
Ecolab Inc. NYSE: ECL	$72.47B 52K%	34.7	United States
Air Products and Chemicals, Inc. NYSE: APD	$67.35B 48K%	-	United States

chevron_leftBack